↓ Skip to main content

High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014

Overview of attention for article published in Journal for Immunotherapy of Cancer, September 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

patent
4 patents

Citations

dimensions_citation
136 Dimensions

Readers on

mendeley
144 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
High dose interleukin-2 (Aldesleukin) - expert consensus on best management practices-2014
Published in
Journal for Immunotherapy of Cancer, September 2014
DOI 10.1186/s40425-014-0026-0
Pubmed ID
Authors

Janice P Dutcher, Douglas J Schwartzentruber, Howard L Kaufman, Sanjiv S Agarwala, Ahmad A Tarhini, James N Lowder, Michael B Atkins

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 144 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 144 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 19 13%
Other 18 13%
Researcher 18 13%
Student > Ph. D. Student 13 9%
Student > Doctoral Student 12 8%
Other 14 10%
Unknown 50 35%
Readers by discipline Count As %
Medicine and Dentistry 33 23%
Immunology and Microbiology 14 10%
Biochemistry, Genetics and Molecular Biology 14 10%
Agricultural and Biological Sciences 14 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Other 10 7%
Unknown 53 37%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 August 2023.
All research outputs
#3,907,044
of 26,017,215 outputs
Outputs from Journal for Immunotherapy of Cancer
#1,066
of 3,487 outputs
Outputs of similar age
#38,948
of 250,108 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 13 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,108 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.